|
Other Publications Pertaining to ADDLs and Alzheimer’s disease
 Aß toxicity in Alzheimer’s disease: globular oligomers (ADDLs) as new vaccine and drug targets
William L. Klein
Neurochemistry International (2002) Vol. 41, 345–352
[Abstract] [Full Paper] - Globular amyloid ß-peptide1-42 oligomer -- a homogenous and stable neuropathological protein in Alzheimer’s diseasStefan Barghorn, Volker Nimmrich, Andreas Striebinger, Carsten Krantz,, Patrick Keller, Bodo Janson, Michael Bahr, Martin Schmidt, Robert S. Bitner, John Harlan, Eve Barlow, Ulrich Ebert and Heinz Hillen
Journal of Neurochemistry (2005) 1-14
[Abstract] [Full Paper]
- A specific amyloid-β protein assembly in the brain impairs memory
Sylvain Lesne, Ming Teng Koh, Linda Kotilinek, Rakez Kayed, Charles G. Glabe, Austin Yang, Michela Gallagher & Karen H. Ashe
Nature (2006) Vol. 440, No. 16, 352-357
[Abstract] [Full Paper]
- Progress on Alzheimer’s disease
2004-2005
National Institute of Aging; National Institutes of Health; U.S. Department of Health and Human Services [Full Paper]
|
